Expand your team to include drug development experts with deep industry knowledge
TSRL complements academic research teams with the addition of product development and commercialization strategy expertise. Our senior project leaders each have over 35 years industry experience in advancing and de-risking drug product development. As a part of our commitment to maximizing the commercial potential of each asset, we will contribute resources for cost-effective business development and marketing.
Champion your fundraising efforts around in-kind investments and non-dilutive government funds
Adding a strong support team improves the overall chances of your project receiving funding awards, as well as maximizing its scope and duration. TSRL, Inc. partners with academic researchers on government grants in areas where our interests overlap. We have secured over $21M for our projects to date and have a 40% success rate with our proposals over the last ten years. We help craft a competitive application complete with a commercialization plan. We can also fill the role of the principal investigator (PI) in grant applications and lead the commercialization plan writing.
Types of Grants: SBIR Phase I/II/III, NIH contracts, Program grants (i.e. UO1), RFAs (i.e. RO1 biodefense)
Streamlined process to de-risk your technology with established preclinical development teams
TSRL, Inc. has extensive expertise in chemistry, pharmacokinetic/dynamic (PK/PD), formulation, exploratory toxicology and development of clinical plans, designed to define clinical drug delivery strategies and dosing regimen. We go beyond traditional accelerators by offering 5,000 sq. ft of wet lab space and AAALAC-accredited animal laboratories, together with on-site analytical chemistry, formulation, cell culture equipment and capabilities. We can generate preliminary in vitro ADME, in vivo PK/PD, formulation, and exploratory toxicology data. Office space and administrative support are also available.
